Citation Impact
Citing Papers
Malignant cerebral glioma—I: Survival, disability, and morbidity after radiotherapy
1996
Positron emission tomography11C-methionine and survival in patients with low-grade gliomas
2001
Effect of Distributing an Evidence-Based Guideline for Prevention of Osteoporosis on Health Education Programs in Municipal Health Centers: A Randomized Controlled Trial
2012
Association between presence of HLA-B*5701, HLA-DR7 , and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir
2002 Standout
Small-Vessel Vasculitis
1997 Standout
Novel interferon-γ enzyme-linked immunoSpot assay using activated cells for identifying hypersensitivity-inducing drug culprits
2017 StandoutNobel
The epidemiology of the epilepsies
2012
SCORTEN: A Severity-of-Illness Score for Toxic Epidermal Necrolysis
2000 Standout
Rhabdomyolysis and Acute Kidney Injury
2009 Standout
Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature
2005
TFOS DEWS II pathophysiology report
2017 Standout
Guidelines on management of low‐grade gliomas: report of an EFNS–EANO* Task Force
2010
The Role of Surgery in Low Grade Gliomas
1999
Metabolic activation in drug allergies
2001
Drug-Induced Severe Skin Reactions
1995
Epidermal growth factor receptor: An independent predictor of survival in astrocytic tumors given definitive irradiation
1996
Malignant Gliomas in Adults
2008 Standout
Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal Necrolysis
1995 Standout
Severe Adverse Cutaneous Reactions to Drugs
1994 Standout
Foetal malformations and seizure control: 52 months data of the Australian Pregnancy Registry
2006
Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol
2006 Standout
Carbamazepine is not a substrate for P‐glycoprotein
2001
Primary brain tumours in adults
2012 Standout
Prenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood Autism
2013 Standout
Herb-Drug Interactions
2005 Standout
Rhabdomyolysis: A review
2002
A marker for Stevens–Johnson syndrome
2004 StandoutNature
Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient Survival
1998 Standout
Brain Tumors
2001 Standout
Printed educational materials: effects on professional practice and healthcare outcomes
2012 Standout
ILAE Official Report: A practical clinical definition of epilepsy
2014 Standout
TNFα promoter region gene polymorphisms in carbamazepine-hypersensitive patients
2001
Cutaneous Drug Reactions
2001
Works of Dave Smith being referenced
Carbamazepine‐hypersensitivity: assessment of clinical and in vitro chemical cross‐reactivity with phenytoin and oxcarbazepine.
1991
Epilepsy in the UK: Misdiagnosis, mistreatment, and undertreatment?
2005
A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial
2007
Prevention of osteoporosis in glucocorticoid-treated neurology patients
2005
Development of prognostic index for primary supratentorial intracerebral tumours.
1992
The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalised epilepsies.
2004
The prognosis of primary intracerebral tumours presenting with epilepsy: the outcome of medical and surgical management.
1991